The gemcitabine HCl market is expected to witness significant growth during the forecast period. Varied R&D activities are contributing to the growth of the market. Growing cancer cases, especially in females such as breast and ovarian cancer, drives the gemcitabine HCl market. COVID-19 also had a major impact on the market growth.
